This journal is an international medium directed towards the needs of academic, clinical, government and industrial analysis by publishing original research reports and critical reviews on pharmaceutical and biomedical analysis. It covers the interdisciplinary aspects of analysis in the pharmaceutical, biomedical and clinical sciences, including developments in analytical methodology, instrumentation, computation and interpretation. Submissions on novel applications focusing on drug purity and stability studies, pharmacokinetics, therapeutic monitoring, metabolic profiling; drug-related aspects of analytical biochemistry and forensic toxicology; quality assurance in the pharmaceutical industry are also welcome.

Studies from areas of well established and poorly selective methods, such as UV-VIS spectrophotometry (including derivative and multi-wavelength measurements), basic electroanalytical (potentiometric, polarographic and voltammetric) methods, fluorimetry, flow-injection analysis, etc. are accepted for publication in exceptional cases only, if a unique and substantial advantage over presently known systems is demonstrated. The same applies to the assay of simple drug formulations by any kind of methods and the determination of drugs in biological samples based merely on spiked samples. Drug purity/stability studies should contain information on the structure elucidation of the impurities/degradants.

本期刊是一所国际性媒体，旨在满足学术、临床、政府和工业分析的需求，发表关于制药和生物医学分析的原创研究报告和评论。它涵盖制药、生物医学和临床科学分析的跨学科方面，包括分析方法、仪器、计算和解释方面的发展。也欢迎提交关于药物纯度和稳定性研究、药代动力学、治疗监测、代谢分析的新应用；分析生物化学和法医毒理学的药物相关方面；制药行业的质量保证。

来自成熟和选择性较差的方法领域的研究，如紫外可见分光光度法（包括导数和多波长测量）、基本电分析（电位法、极谱法和伏安法）方法、荧光法、流动注射分析等，只有在特殊情况下，如果证明比目前已知的系统具有独特和实质性的优势，才接受发表。这同样适用于通过任何类型的方法对简单药物制剂进行分析，以及仅基于加标样品对生物样品中的药物进行测定。药物纯度/稳定性研究应包含有关杂质/降解物结构解析的信息。

该刊已被国际权威数据库SCIE收录，该刊致力于发表经过严格同行评审的高质量原创文章，反映医学-分析化学领域的新进展、新技术、新成果，促进该领域科研交流和科研成果转化。该刊2023年影响因子为3.1，平均审稿速度为 约2.0个月 约6.5周，近四年来没有被列入预警名单。如果您需要投稿发表服务及指导，可以联系我们的客服老师，我们专业专注服务期刊投稿协助10年，为您提供期刊投稿个性化定制服务，并且我们确保严格保密您的个人信息及稿件内容。